Phase 2 trial of talabostat in stage IV melanoma.

被引：0
|
作者：
Redman, BG
Ernstoff, MS
Gajewski, TF
Cunningham, C
Lawson, DH
Gregoire, L
Haltom, E
Uprichard, MJ
机构：
[1] Univ Michigan, Comp Canc Ctr, Ann Arbor, MI 48109 USA
[2] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[3] Univ Chicago, Chicago, IL 60637 USA
[4] Mary Crowley Med Res Ctr, Dallas, TX USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Point Therapeut, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：727S / 727S
页数：1
相关论文
共 50 条
  • [41] Phase II trial evaluating docetaxel and vinorelbine with GM-CSF in stage IV melanoma
    Fruehauf, John
    Jakowatz, James
    Kong, Kevin
    Antonio, Sanchez
    Eroglu, Zeynep
    CANCER RESEARCH, 2009, 69
  • [42] Final results of a phase II immunotherapy trial for stage III and IV melanoma patients.
    Riker, Adam Irwin
    Rossi, Gabriela R.
    Alsfeld, Leonard C.
    Denham, Fiona
    Tennant, Lucinda
    Ramsey, William Jay
    Link, Charles J.
    Harrison, Marilynn
    Vahanian, Nicholas N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma.
    Morton, DL
    Essner, R
    Hsueh, EC
    Wanek, LA
    Foshag, LJ
    O'Day, SJ
    Gupta, RK
    Hoon, DS
    Gammon, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 173S - 173S
  • [44] Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma.
    Bloom, Jon
    Donia, Marco
    Andersen, Rikke
    Hadrup, Sine Raker
    Lyngaa, Rikke
    Svane, Inge Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Final results of a pilot study using sunitinib malate in patients with stage IV uveal melanoma.
    Tijani, L. A.
    Luadadio, M.
    Mastrangelo, M. J.
    Sato, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Effect of denileukin diftitox on serum GM-CSF and clinical responses in stage IV melanoma.
    Chesney, J.
    Rasku, M. A.
    Klarer, A. C.
    Miller, D. M.
    Telang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] A phase 2 trial of high-dose allovectin-7 in patients with advanced metastatic melanoma.
    Richards, J
    Bedikian, AY
    Gonzalez, R
    Atkins, MB
    Whitman, ED
    Lutzky, J
    Morse, MA
    Amatruda, T
    Galanis, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 712S - 712S
  • [48] A phase I trial of riluzole and sorafenib in patients with advanced solid tumors and melanoma.
    Mehnert, Janice M.
    Semlani, Neha
    Wen, Yvonne
    Tan, Antoinette R.
    Moss, Rebecca Anne
    Adams, Shari
    Stein, Mark N.
    Ross, Mikel
    Kane, Michael P.
    Gibbon, Darlene
    Wright, John Joseph
    Aisner, Joseph
    Chen, Suzie
    Goydos, James S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] A phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with advanced melanoma.
    Shaikh, Saba
    Zang, Yan
    Hanmer, Janel
    Wang, Hong
    Lin, Yan
    Davar, Diwakar
    Zarour, Hassane M.
    Kirkwood, John M.
    Najjar, Yana G.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] A phase I, open-label, cohort study of two doses of coxsackievirus A21 given intratumorally in stage IV melanoma.
    Shafren, D.
    Smithers, B. M.
    Formby, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345